Petros Grivas, MD, PhD | Authors


Avelumab Plus Best Supportive Care Shows Efficacy in Urothelial Carcinoma

June 24, 2020

Petros Grivas, MD, PhD, discusses the JAVELIN Bladder 100 trial of maintenance avelumab plus best supportive care versus best supportive care alone after platinum-based first-line chemotherapy in patients with advanced urothelial carcinoma.